(Reuters) - GlaxoSmithKline Plc on Thursday confirmed it was considering a merger of its consumer healthcare business as part of a review of its Indian Horlicks nutrition business and other consumer healthcare nutrition products.
GSK did not clarify who the unit could be merged with or provide further details. GSK was not immediately available for comment.
CNBC TV18 had reported earlier on Thursday that consumer goods group Unilever may look at merging GSK Consumer Healthcare with Unilever's Indian unit HUL.
Unilever emerged as the leading bidder in a tight contest for the Horlicks business, three people familiar with the situation told Reuters on Wednesday.
(Reporting by Arathy S Nair in Bengaluru; Editing by Bernard Orr)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app